Beware of "supplement imbalance" of local base drugs

After the introduction of the new catalogue of national essential drugs, the supplement of local essential drugs is in full swing According to media reports, Qinghai Province plans to add 200 species, Guangdong Province plans to add 269 species, and other provinces plan to add roughly between the two provinces In order to increase the effectiveness and suitability of local drug supplement, we must grasp the "three principles" and guard against the "imbalance of supplement" First, the medical insurance fund is not overdrawn It should be in line with the basic spirit and requirements of the new medical reform for all localities to appropriately supplement the quantity of basic drugs in combination with the characteristics of disease onset, especially for the treatment needs of local diseases, or for the consideration of prevention and control of epidemics or major epidemics However, adding the number of local basic drugs will inevitably increase the expenditure of medical insurance, which will bring certain pressure to the general medical insurance fund If the control is not good, there will be the problem of overdraft or serious overdraft of local medical insurance funds, which will affect the overall progress of the new medical reform to a certain extent Therefore, it should be one of the principles to properly deal with the relationship between the supplement of local essential drugs and the sufficiency of medical insurance funds Of course, for regions with strong economic strength, the problem of overdraft of medical insurance fund will not occur when the number of local basic drug varieties is supplemented, and it can also be allowed to try first, and it is unnecessary to make rigid regulations Second, the inclusion of management is no exception All kinds of basic drugs supplemented by local governments must be included in various systems of national basic drug management If they are separated from the system or engaged in another set, they will naturally lead to problems such as excessive medical treatment, drug-based care, disguised addition, and lead to more serious problems such as the loss of medical insurance funds and the pursuit of improper interests by drugs Therefore, it is necessary to make sure that the varieties of basic drugs supplemented by local governments are included in the list and shortlisted in management All approved varieties of local basic drugs shall be managed by reference to the national basic drug management system, and shall not be allowed to open up the management for any reason and make modifications in the implementation In the strict implementation of the national basic drug management system, such as centralized bidding, zero price difference of basic drugs, two lines of revenue and expenditure, electronic supervision, etc., we should ensure that the management of local basic drugs is implemented, and make the local basic drugs supplement work become the booster of the new medical reform Third, we should ensure fairness In the current situation of serious overcapacity of China's pharmaceutical industry and downward pressure on local pharmaceutical economy, it is not ruled out that a small number of places incline to local pharmaceutical enterprises through the verification of local basic drug supplement varieties, the design of bidding system and other aspects In this way, it must lead to the exclusion of other regions in the market share distribution of local based drugs, thus forming a new local protectionism Therefore, in the examination and approval of the supplementary varieties of local base drugs, it is necessary to control the exclusive varieties to the greatest extent, especially the local exclusive varieties, strictly implement the procurement system of local base drugs, ensure the transparency of the whole process from procurement to use of local base drugs, and ensure the fairness of the pharmaceutical market Those who set up artificial barriers should be strictly investigated and punished in order to maintain the seriousness of base drug management and put an end to the bad behaviors that disrupt the market order.